Human papillomaviruses and centrosome duplication errors: Modeling the origins of genomic instability

Oncogene

Volumn 21, Issue 40 REV. ISS. 4, 2002, Pages 6241-6248

  Duensing, Stefan ^a   Münger, Karl ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Centrosomes; Cervical cancer; Genomic instability; HPV

Indexed keywords

ONCOPROTEIN;

ANEUPLOIDY; CARCINOGENESIS; CELL DIVISION; CENTROSOME; ENZYME ACTIVITY; ERROR; GENE DISRUPTION; GENE DUPLICATION; GENETIC RISK; GENOME; HOMEOSTASIS; MALIGNANT TRANSFORMATION; MITOSIS; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; WART VIRUS;

CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; CENTROSOME; GENOME; HUMANS; PAPILLOMAVIRIDAE; VIRUS REPLICATION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0037048297     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205709     Document Type: Review

References (74)

1. Baksch C, Wagenbach N, Nonn M, Leistritz S, Stanbridge E, Schneider A and Dürst M. (2001). Genes Chrom. Cancer, 31, 196-198.
2. Bardelli A, Cahill DP, Lederer G, Speicher MR, Kinzler KW, Vogelstein B and Lengauer C. (2001). Proc. Natl. Acad. Sci. USA, 98, 5770-5775.
3. Berezutskaya E and Bagchi S. (1997). J. Biol, Chem., 272, 30135-30140.
4. Bibbo M, Dytch HE, Alenghat E, Bartels PH and Wied GL. (1989). Am. J, Clin. Pathol., 92, 261-265.
5. Boveri T. (1914). Zur Frage der Entstehung maligner Tumoren. G Fischer: Jena.
6. Boyer SN, Wazer DE and Band V. (1996). Cancer Res., 56, 4620-4624.
7. Brehm A, Nielsen SJ, Miska EA, McCance DJ, Reid JL, Bannister AJ and Kouzarides T. (1999). EMBO J., 18, 2449-2458.
8. Bulten J, Poddighe PJ, Robben JCM, Gemmink JH, de Wilde PCM and Hanselaar AGJM. (1998). Am. J. Pathol., 152, 495-503.
9. Cahill DP, Kinzler KW, Vogelstein B and Lengauer C. (1999). Trends Cell. Biol., 9, M57-M60.
10. Crum CP, Ikenberg H, Richart RM and Gissman L. (1984). N. Engl. J. Med., 310, 880-883.
11. Dollard SC, Wilson JL, Demeter LM, Bonnez W, Reichman RC, Broker TR and Chow LT. (1992). Genes Dev., 6, 1131-1142.
12. Duensing S, Duensing A, Crum CP and Munger K. (2001a). Cancer Res., 61, 2356-2360.
13. Duensing S, Duensing A, Flores ER, Do A, Lambert PF and Munger K. (2001b). J. Virol., 75, 7712-7716.
14. Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S, Crum CP and Munger K. (2000). Proc. Natl. Acad. Sci. USA, 97, 10002-10007.
15. Duensing S and Munger K. (2001). Biochim. Biophys. Acta, 2, M81-M88.
16. Dyson N, Howley PM, Munger K and Harlow E. (1989). Science, 243, 934-937.
17. Fisk HA and Winey M. (2001). Cell, 106, 95-104.
18. Flores ER, Allen-Hoffmann BL, Lee D, Sattler CA and Lambert PF. (1999). Virology, 262, 344-354.
19. Fu YS, Reagan JW and Richart RM. (1981). Gynecol. Oncol., 12, S220-S231.
20. Funk JO, Waga S, Harry JB, Espling E, Stillman Band Galloway DA. (1997). Genes Dev., 11, 2090-2100.
21. Gisselsson D. (2001). Atlas Genet. Cytogenet. Oncol. Hematol. URL://www.infobiogen.fr/services/chromcancer /Deep/ChromosomInstabilID20023.html.
22. Hashida T and Yasumoto S. (1991). J. Gen. Virol., 72, 1569-1577.
23. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR and Schiller JT. (1989). EMBO J., 8, 3905-3910.
24. Hinchcliffe EH, Li C, Thompson EA, Maller JL and Sluder G. (1999). Science, 283, 851-854.
25. Hittelman WN. (2001). Ann. N.Y. Acad. Sci., 952, 1-12.
26. Howley PM and Lowy DR. (2001). Field's Virology Vol. 2., Knipe DM and Howley PM (eds). Philadelphia: Lippincott Williams and Wilkins, pp. 2197-2229.
27. Huibregtse JM, Scheffner M and Howley PM. (1991). EMBO J., 10, 4129-4135.
28. Huibregtse JM, Scheffner M, Beaudenon S and Howley PM. (1995). Proc. Natl. Acad. Sci. USA, 92, 2563-2567.
29. Hurlin PJ, Kaur P, Smith PP, Perez-Reyes N, Blanton RA and McDougall JK. (1991). Proc. Natl. Acad. Sci. USA, 88, 570-574.
30. Jones DL, Alani RM and Munger K. (1997). Genes Dev., 11, 2101-2111.
31. Jones HW, Katayama KP, Stafl A and Davis HJ. (1967). Obst. Gynecol., 30, 790-805.
32. Kashyap V and Das BC. (1998). Cancer Lett., 123, 47-52.
33. Katich SC, Zerfass-Thome K and Hoffmann I. (2001). Oncogene, 20, 543-550.
34. Kessis TD, Connolly DC, Hedrick L and Cho KR. (1996). Oncogene, 13, 427-431.
35. Klingelhutz AJ, Foster SA and McDougall JK. (1996). Nature, 380, 79-82.
36. Koi M, Morita H, Yamada H, Satoh H, Barrett JC and Oshimura M. (1989). Mol. Carcinog., 2, 12-21.
37. Lacey KR, Jackson PK and Stearns T. (1999). Proc. Natl. Acad. Sci. USA, 96, 2817-2822.
38. Larson AA, Liao SY, Stanbridge EJ, Cavenee WK and Hampton GM. (1997). Cancer Res., 57, 4171-4176.
39. Lengauer C, Kinzler KW and Vogelstein B. (1998). Nature, 396, 643-649.
40. Lingle WL, Lutz WH, Ingle JN, Maihle NJ and Salisbury JL. (1998). Proc. Natl. Acad. Sci. USA, 95, 2950-2955.
41. Lowy DR and Howley PM. (2001). Field's Virology Vol. 2., Knipe DM and Howley PM (eds). Philadelphia: Lippincott Williams and Wilkens, pp. 2231-2264.
42. Martin LG, Demers GW and Galloway DA. (1998). J. Virol., 72, 975-985.
43. Matsumoto Y, Hayashi K and Nishida E. (1999). Curr. Biol., 9, 429-432.
44. McCance DJ, Kopan R, Fuchs E and Laimins LA. (1988). Proc. Natl. Acad. Sci. USA, 85, 7169-7173.
45. Meraldi P, Honda R and Nigg EA. (2002). EMBO J., 21, 483-492.
46. Meraldi P, Lukas J, Fry AM, Bartek J and Nigg EA. (1999). Nat. Cell Biol., 1, 88-93.
47. Meyers C, Frattini MG, Hudson JB and Laimins LA. (1992). Science, 257, 971-973.
48. Munger K. (2002). Front. Biosci., 7, 641-649.
49. Munger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M and Zacny VL. (2001). Oncogene, 20, 7888-7898.
50. Munger K, Phelps WC, Bubb V, Howley PM and Schlegel R. (1989). J. Virol., 63, 4417-4421.
51. Muthuswamy SK, Li D, Lelievre S, Bissell MJ and Brugge JS. (2001). Nat. Cell Biol., 3, 785-792.
52. Okuda M, Horn HF, Tarapore P, Tokuyama Y, Smulian AG, Chan PK, Knudsen ES, Hofmann IA, Snyder JD, Bove KE and Fukasawa K. (2000). Cell, 103, 127-140.
53. Pihan GA and Doxsey SJ. (1999). Sem. Cancer Biol., 9, 289-302.
54. Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P and Doxsey SJ. (1998). Cancer Res., 58, 3974-3985.
55. Poignee M, Backsch C, Beer K, Jansen L, Wagenbach N, Stanbridge EJ, Kirchmayr R, Schneider A and Durst M. (2001). Cancer Res., 61, 7118-7121.
56. Reid R, Crum CP, Herschman BR, Fu YS, Braun L, Shah KV, Agronow SJ and Stanhope CR. (1984). Cancer, 53, 943-953.
57. Rihet S, Lorenzato M and Clavel C. (1996). J. Clin. Pathol., 49, 892-896.
58. Scheffner M, Huibregtse JM, Vierstra RD and Howley PM. (1993). Cell, 75, 495-505.
59. Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM. (1990). Cell, 63, 1129-1136.
60. Schulze A, Mannhardt B, Zerfass-Thome K, Zwerschke W and Jansen-Durr P. (1998). J. Virol., 72, 2323-2334.
61. Skyldberg B, Fujioka K, Hellstrom AC, Sylven L, Moberger B and Auer G. (2001). Mod. Pathol., 14, 279-284.
62. Solinas-Toldo S, Dürst M and Lichter P. (1997). Proc. Natl. Acad. Sci. USA, 94, 3854-3859.
63. Southern SA, Evans MF and Herrington CS. (1997). Cancer Res., 57, 4210-4213.
64. Southern SA, Noya F, Meyers C, Broker TR, Chow LT and Herrington CS. (2001). Cancer Res., 61, 4858-4863.
65. Steinbeck RG. (1997). Acta Oncol., 36, 3-12.
66. Uejima H, Mitsuya K, Kugoh H, Horikawa I and Oshimura M. (1995). Genes Chrom. Cancer, 14, 120-127.
67. Vogelstein B, Lane D and Levine AJ. (2000). Nature, 408, 307-310.
68. Werness BA, Levine AJ and Howley PM. (1990). Science, 248, 76-79.
69. White AE, Livanos EM and Tlsty TD. (1994). Genes Dev., 8, 666-677.
70. World Health Organisation. (1995). IARC Monogr. Eval. Carcinog. Risks Hum., 64, 35-378.
71. Zerfass K, Schulze A, Spitkovsky D, Friedman V, Henglein B and Jansen-Durr P. (1995). J. Virol., 69, 6389-6399.
72. Zerfass-Thome K, Zwerschke W, Mannhardt B, Tindle R, Botz JW and Jansen-Durr P. (1996). Oncogene, 13, 2323-2330.
73. zur Hausen H. (1991). Science, 254, 1167-1173.
74. zur Hausen H. (1996). Biochim. Biophys. Acta, 1288, F55-F78.